These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38412638)
1. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638 [TBL] [Abstract][Full Text] [Related]
2. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition. Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103 [TBL] [Abstract][Full Text] [Related]
3. Prospective analysis of circulating metabolites and breast cancer in EPIC. His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832 [TBL] [Abstract][Full Text] [Related]
4. Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition. Kliemann N; Viallon V; Murphy N; Beeken RJ; Rothwell JA; Rinaldi S; Assi N; van Roekel EH; Schmidt JA; Borch KB; Agnoli C; Rosendahl AH; Sartor H; Huerta JM; Tjønneland A; Halkjær J; Bueno-de-Mesquita B; Gicquiau A; Achaintre D; Aleksandrova K; Schulze MB; Heath AK; Tsilidis KK; Masala G; Panico S; Kaaks R; Fortner RT; Van Guelpen B; Dossus L; Scalbert A; Keun HC; Travis RC; Jenab M; Johansson M; Ferrari P; Gunter MJ BMC Med; 2021 Apr; 19(1):101. PubMed ID: 33926456 [TBL] [Abstract][Full Text] [Related]
5. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients. Vouk K; Ribič-Pucelj M; Adamski J; Rižner TL J Steroid Biochem Mol Biol; 2016 May; 159():60-9. PubMed ID: 26921767 [TBL] [Abstract][Full Text] [Related]
6. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study. Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845 [TBL] [Abstract][Full Text] [Related]
7. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Murphy N; Cross AJ; Abubakar M; Jenab M; Aleksandrova K; Boutron-Ruault MC; Dossus L; Racine A; Kühn T; Katzke VA; Tjønneland A; Petersen KE; Overvad K; Quirós JR; Jakszyn P; Molina-Montes E; Dorronsoro M; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Ericson U; Palmqvist R; Nyström H; Weiderpass E; Skeie G; Freisling H; Kong SY; Tsilidis K; Muller DC; Riboli E; Gunter MJ PLoS Med; 2016 Apr; 13(4):e1001988. PubMed ID: 27046222 [TBL] [Abstract][Full Text] [Related]
8. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. Breeur M; Ferrari P; Dossus L; Jenab M; Johansson M; Rinaldi S; Travis RC; His M; Key TJ; Schmidt JA; Overvad K; Tjønneland A; Kyrø C; Rothwell JA; Laouali N; Severi G; Kaaks R; Katzke V; Schulze MB; Eichelmann F; Palli D; Grioni S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Olsen KS; Sandanger TM; Nøst TH; Quirós JR; Bonet C; Barranco MR; Chirlaque MD; Ardanaz E; Sandsveden M; Manjer J; Vidman L; Rentoft M; Muller D; Tsilidis K; Heath AK; Keun H; Adamski J; Keski-Rahkonen P; Scalbert A; Gunter MJ; Viallon V BMC Med; 2022 Oct; 20(1):351. PubMed ID: 36258205 [TBL] [Abstract][Full Text] [Related]
9. The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium. Guida F; Tan VY; Corbin LJ; Smith-Byrne K; Alcala K; Langenberg C; Stewart ID; Butterworth AS; Surendran P; Achaintre D; Adamski J; Amiano P; Bergmann MM; Bull CJ; Dahm CC; Gicquiau A; Giles GG; Gunter MJ; Haller T; Langhammer A; Larose TL; Ljungberg B; Metspalu A; Milne RL; Muller DC; Nøst TH; Pettersen Sørgjerd E; Prehn C; Riboli E; Rinaldi S; Rothwell JA; Scalbert A; Schmidt JA; Severi G; Sieri S; Vermeulen R; Vincent EE; Waldenberger M; Timpson NJ; Johansson M PLoS Med; 2021 Sep; 18(9):e1003786. PubMed ID: 34543281 [TBL] [Abstract][Full Text] [Related]
10. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. Jenab M; Bueno-de-Mesquita HB; Ferrari P; van Duijnhoven FJ; Norat T; Pischon T; Jansen EH; Slimani N; Byrnes G; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Kaaks R; Linseisen J; Boeing H; Bergmann MM; Trichopoulou A; Misirli G; Trichopoulos D; Berrino F; Vineis P; Panico S; Palli D; Tumino R; Ros MM; van Gils CH; Peeters PH; Brustad M; Lund E; Tormo MJ; Ardanaz E; Rodríguez L; Sánchez MJ; Dorronsoro M; Gonzalez CA; Hallmans G; Palmqvist R; Roddam A; Key TJ; Khaw KT; Autier P; Hainaut P; Riboli E BMJ; 2010 Jan; 340():b5500. PubMed ID: 20093284 [TBL] [Abstract][Full Text] [Related]
11. Prospective study of blood metabolites associated with colorectal cancer risk. Shu X; Xiang YB; Rothman N; Yu D; Li HL; Yang G; Cai H; Ma X; Lan Q; Gao YT; Jia W; Shu XO; Zheng W Int J Cancer; 2018 Aug; 143(3):527-534. PubMed ID: 29479691 [TBL] [Abstract][Full Text] [Related]
12. Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts. Karavasiloglou N; Hughes DJ; Murphy N; Schomburg L; Sun Q; Seher V; Rohrmann S; Weiderpass E; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Kaaks R; Kuhn T; Schulze MB; Tumino R; Panico S; Masala G; Pala V; Sacerdote C; Derksen JWG; Skeie G; Hjartåker A; Lasheras C; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Amiano P; Van Guelpen B; Gylling B; Bradbury KE; Papier K; Freisling H; Aglago EK; Cross AJ; Riboli E; Aune D; Gunter MJ; Jenab M Am J Clin Nutr; 2023 Jan; 117(1):33-45. PubMed ID: 36789942 [TBL] [Abstract][Full Text] [Related]
13. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study. Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240 [TBL] [Abstract][Full Text] [Related]
15. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. Kühn T; Floegel A; Sookthai D; Johnson T; Rolle-Kampczyk U; Otto W; von Bergen M; Boeing H; Kaaks R BMC Med; 2016 Jan; 14():13. PubMed ID: 26817443 [TBL] [Abstract][Full Text] [Related]
16. Soluble Receptor for Advanced Glycation End-products (sRAGE) and Colorectal Cancer Risk: A Case-Control Study Nested within a European Prospective Cohort. Aglago EK; Rinaldi S; Freisling H; Jiao L; Hughes DJ; Fedirko V; Schalkwijk CG; Weiderpass E; Dahm CC; Overvad K; Eriksen AK; Kyrø C; Boutron-Ruault MC; Rothwell JA; Severi G; Katzke V; Kühn T; Schulze MB; Aleksandrova K; Masala G; Krogh V; Panico S; Tumino R; Naccarati A; Bueno-de-Mesquita B; van Gils CH; Sandanger TM; Gram IT; Skeie G; Quirós JR; Jakszyn P; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Johansson I; Harlid S; Perez-Cornago A; Mayén AL; Cordova R; Gunter MJ; Vineis P; Cross AJ; Riboli E; Jenab M Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):182-192. PubMed ID: 33082206 [TBL] [Abstract][Full Text] [Related]
17. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC. Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192 [TBL] [Abstract][Full Text] [Related]